2,0
11 set 2014
Dipendente attuale, più di 8 anni
New York, NY
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Very diversified company. Good exposure to both Life Sciences and Industrial business. Benefits in general are good but the endless cost cutting is taking a toll.
Svantaggi
Senior leadership's goals are clearly short term. Financial community seems to not notice the complete lack of a long term strategy. Benefits and resource cost cutting are being offset by excessive executive compensation.